Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

CVS Health Corp., decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2024 = ×
Dec 31, 2023 = ×
Dec 31, 2022 = ×
Dec 31, 2021 = ×
Dec 31, 2020 = ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


Return on Assets (ROA)
The Return on Assets demonstrated fluctuations over the observed periods. Starting at 3.11% at the end of 2020, it increased slightly to 3.39% in 2021 before experiencing a notable decline to 1.82% in 2022. This was followed by a rebound to 3.34% in 2023, but the metric decreased once again to 1.82% in 2024. The pattern suggests variability in asset efficiency and profitability, with no consistent upward or downward trend across the years.
Financial Leverage
The financial leverage ratio remained relatively stable, with values oscillating slightly around the 3.2 mark. It started at 3.32 at the end of 2020, decreased to 3.1 in 2021, and then increased moderately through 2022 to 3.21, 2023 to 3.27, and finally to 3.35 in 2024. This slight upward tendency in recent years indicates a mild increase in the use of debt relative to equity, suggesting a subtle shift toward more leveraged financing.
Return on Equity (ROE)
ROE exhibited a pattern similar to the ROA, showing variability with periods of growth and decline. It was 10.35% at the end of 2020 and increased slightly to 10.54% in 2021. However, it fell sharply to 5.84% in 2022 before rising again to 10.91% in 2023, followed by another decrease to 6.11% in 2024. This oscillation indicates fluctuations in overall profitability and the returns generated for shareholders, correlating somewhat with the asset return trends but amplified by changes in leverage.

Three-Component Disaggregation of ROE

CVS Health Corp., decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2024 = × ×
Dec 31, 2023 = × ×
Dec 31, 2022 = × ×
Dec 31, 2021 = × ×
Dec 31, 2020 = × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


Net Profit Margin
The net profit margin exhibited fluctuations over the observed periods, starting at 2.68% in 2020 and slightly increasing to 2.72% in 2021. It then declined markedly to 1.29% in 2022 before recovering to 2.34% in 2023, and finally dropping again to 1.24% in 2024. This indicates variability in profitability relative to revenue, suggesting potential challenges in cost management or pricing strategies during certain years.
Asset Turnover
Asset turnover showed a consistent upward trend throughout the time frame, rising from 1.16 in 2020 to 1.46 in 2024. This improvement signals increasing efficiency in utilizing assets to generate sales, reflecting positive operational performance and potentially effective asset management policies.
Financial Leverage
Financial leverage ratios remained relatively stable, fluctuating slightly between 3.10 and 3.35. After a decrease from 3.32 in 2020 to 3.10 in 2021, the ratio gradually increased to 3.35 by 2024. This suggests steady use of debt relative to equity, with no significant shifts in capital structure during the period.
Return on Equity (ROE)
Return on equity mirrored the fluctuations observed in net profit margin, starting at 10.35% in 2020 and showing a slight increase to 10.54% in 2021. A notable decline occurred in 2022, falling to 5.84%, followed by recovery to 10.91% in 2023, and a subsequent decline to 6.11% in 2024. These variations indicate variability in profitability relative to shareholders' equity, influenced by both profitability and leverage factors.

Five-Component Disaggregation of ROE

CVS Health Corp., decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2024 = × × × ×
Dec 31, 2023 = × × × ×
Dec 31, 2022 = × × × ×
Dec 31, 2021 = × × × ×
Dec 31, 2020 = × × × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


Tax Burden
The tax burden ratio remained relatively stable across the analyzed years, fluctuating slightly around 0.74 to 0.76. This indicates consistent tax efficiency with no significant changes in tax impact on pre-tax earnings over the period.
Interest Burden
The interest burden ratio exhibited more variability. After increasing from 0.77 in 2020 to a peak of 0.81 in 2021, it declined sharply to 0.71 in 2022, recovered back to 0.81 in 2023, and then dropped to its lowest point of 0.68 in 2024. This suggests fluctuations in interest expense relative to earnings before interest and taxes, affecting net profitability through varying degrees of interest cost burden.
EBIT Margin
The EBIT margin showed a declining trend over the period. Starting at 4.72% in 2020, it decreased slightly to 4.45% in 2021, then dropped significantly to 2.46% in 2022. There was a partial recovery to 3.87% in 2023, but it fell again to 2.46% in 2024. This indicates reduced operating profitability, suggesting challenges in controlling operating costs or generating operating income relative to revenue in recent years.
Asset Turnover
Asset turnover demonstrated a consistent upward trend, increasing from 1.16 in 2020 to 1.46 in 2024. This improvement suggests enhanced efficiency in using assets to generate revenue, reflecting positively on management's ability to utilize resources effectively over time.
Financial Leverage
Financial leverage ratios showed minor fluctuations but an overall slight increase from 3.32 in 2020 to 3.35 in 2024, with a dip at 3.10 in 2021. This indicates a marginally higher reliance on debt or other liabilities relative to equity, which may amplify returns but also increases financial risk moderately.
Return on Equity (ROE)
ROE showed significant volatility, starting at 10.35% in 2020, slightly increasing to 10.54% in 2021, then dropping sharply to 5.84% in 2022. It rebounded strongly to 10.91% in 2023 before declining again to 6.11% in 2024. The pattern reflects fluctuating profitability and effectiveness in generating equity returns, likely influenced by variations in operating performance, leverage, and interest burden.

Two-Component Disaggregation of ROA

CVS Health Corp., decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2024 = ×
Dec 31, 2023 = ×
Dec 31, 2022 = ×
Dec 31, 2021 = ×
Dec 31, 2020 = ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The analysis of the financial performance over the periods from December 31, 2020, to December 31, 2024, reveals several notable trends in profitability and asset utilization.

Net Profit Margin
The net profit margin exhibited fluctuation throughout the observed periods. It started at 2.68% in 2020 and slightly increased to 2.72% in 2021. However, there was a significant decline to 1.29% in 2022, followed by a partial recovery to 2.34% in 2023. In 2024, the margin fell again to 1.24%, indicating increased variability and a downward trend in profitability relative to sales over the five-year span.
Asset Turnover
The asset turnover ratio showed a consistent upward trajectory across the entire period. Beginning at 1.16 in 2020, it increased steadily each year, reaching 1.25 in 2021, 1.41 in 2022, 1.43 in 2023, and peaking at 1.46 in 2024. This trend signifies improving efficiency in the use of assets to generate revenue.
Return on Assets (ROA)
ROA mirrored the pattern seen in net profit margin, starting at 3.11% in 2020 and rising to 3.39% in 2021. It then declined notably to 1.82% in 2022 before increasing again to 3.34% in 2023. In 2024, ROA decreased back to 1.82%. This variability suggests fluctuating effectiveness in asset utilization to generate net income, in line with the changes in net profit margin.

Overall, while asset turnover steadily improved, indicating enhanced asset efficiency, the profitability metrics as measured by net profit margin and ROA showed considerable volatility with declining tendencies towards the end of the period. This suggests challenges in maintaining profit levels despite better asset use.


Four-Component Disaggregation of ROA

CVS Health Corp., decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2024 = × × ×
Dec 31, 2023 = × × ×
Dec 31, 2022 = × × ×
Dec 31, 2021 = × × ×
Dec 31, 2020 = × × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


Tax Burden
The tax burden ratio remained relatively stable over the five-year period, fluctuating slightly between 0.74 and 0.76. This indicates consistent tax expense management relative to pre-tax earnings.
Interest Burden
The interest burden exhibited greater variability, beginning at 0.77 in 2020 and increasing to a peak of 0.81 in 2021 and again in 2023, before dropping to 0.68 in 2024. This suggests fluctuations in interest expenses relative to EBIT, with a noticeable reduction in 2024 indicating potentially lower interest expenses or improved earnings before interest and taxes.
EBIT Margin
The EBIT margin showed a declining trend overall, beginning at 4.72% in 2020, with a slight dip in 2021, a significant drop to 2.46% in 2022, a partial recovery to 3.87% in 2023, and falling back to 2.46% in 2024. This pattern reflects weakening operating profitability with some cyclical improvement in 2023 but overall downward pressure on operating efficiency over the period.
Asset Turnover
Asset turnover increased steadily from 1.16 in 2020 to 1.46 in 2024, indicating improving efficiency in utilizing assets to generate sales. The consistent upward trend suggests enhanced operational performance in asset utilization over time.
Return on Assets (ROA)
The ROA experienced fluctuations, following a pattern similar to the EBIT margin. It increased from 3.11% in 2020 to a high of 3.39% in 2021, then declined sharply to 1.82% in 2022, rebounded to 3.34% in 2023, and decreased again to 1.82% in 2024. This volatility reflects underlying challenges in sustaining asset profitability, influenced by both operational performance and cost management factors.

Disaggregation of Net Profit Margin

CVS Health Corp., decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2024 = × ×
Dec 31, 2023 = × ×
Dec 31, 2022 = × ×
Dec 31, 2021 = × ×
Dec 31, 2020 = × ×

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


Tax Burden
The tax burden ratio remained relatively stable over the five-year period, fluctuating slightly between 0.74 and 0.76. This indicates a consistent proportion of income retained after tax expenses, with minimal variation year to year.
Interest Burden
The interest burden ratio displayed more volatility. It increased from 0.77 in 2020 to 0.81 in 2021, suggesting improved capability to cover interest expenses during this period. However, it then declined notably to 0.71 in 2022, rebounded to 0.81 in 2023, and dropped again to 0.68 in 2024. These fluctuations imply inconsistency in managing interest expenses relative to operating income.
EBIT Margin
The EBIT margin showed a declining trend overall. It decreased from 4.72% in 2020 to 2.46% in 2024, with a minor recovery in 2023 reaching 3.87%. The sharp decrease especially in 2022 and 2024 indicates deteriorating operating profitability, possibly due to rising costs, pricing pressure, or other operational challenges.
Net Profit Margin
Net profit margin followed a pattern similar to EBIT margin but at consistently lower levels, reflecting additional deductions below operating income. Starting at 2.68% in 2020, it peaked slightly at 2.72% in 2021 but declined significantly to 1.29% in 2022. A partial recovery occurred in 2023 to 2.34%, followed by a drop to 1.24% in 2024. This variability indicates challenges in overall profitability, perhaps influenced by interest expense fluctuations and tax effects, despite stable tax burden ratios.